Epigenetics in Breast Cancer Therapy-New Strategies and Future Nanomedicine Perspectives

e-NIOS is a partner of the international INNOCENT project, with the aim to develop an innovative multifunctional nano-pharmaceutical to overcome the low efficacy and frequent relapses in breast cancer treatment. The use of nano-based delivery systems, together with the benefits of a new generation of epi-drugs and the emergence of robust biomarker data, will help to advance personalized-targeted therapy and the efficacy of treatment for breast and other cancers. The proposed nano-drug will integrate the diagnostic and therapeutic functions within a single nanostructure.

A new paper is publicly accessible here: https://www.mdpi.com/2072-6694/12/12/3622/htm